Jacobs Levy Equity Management’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-42,074
| Closed | -$207K | – | 1001 |
|
|
2024
Q3 | $207K | Buy |
+42,074
| New | +$207K | ﹤0.01% | 921 |
|
|
2022
Q3 | – | Sell |
-28,549
| Closed | -$285K | – | 1100 |
|
|
2022
Q2 | $285K | Sell |
28,549
-221,883
| -89% | -$2.22M | ﹤0.01% | 933 |
|
|
2022
Q1 | $2.9M | Buy |
250,432
+79,558
| +47% | +$921K | 0.02% | 541 |
|
|
2021
Q4 | $1.9M | Buy |
170,874
+1,199
| +0.7% | +$13.3K | 0.01% | 633 |
|
|
2021
Q3 | $1.56M | Sell |
169,675
-4,786
| -3% | -$44.1K | 0.01% | 663 |
|
|
2021
Q2 | $1.96M | Buy |
174,461
+8,052
| +5% | +$90.6K | 0.01% | 599 |
|
|
2021
Q1 | $1.76M | Buy |
166,409
+94,064
| +130% | +$997K | 0.01% | 627 |
|
|
2020
Q4 | $785K | Buy |
72,345
+24,013
| +50% | +$261K | 0.01% | 771 |
|
|
2020
Q3 | $470K | Buy |
+48,332
| New | +$470K | ﹤0.01% | 804 |
|
|
2020
Q1 | – | Sell |
-11,588
| Closed | -$131K | – | 1050 |
|
|
2019
Q4 | $131K | Buy |
+11,588
| New | +$131K | ﹤0.01% | 966 |
|
|
2018
Q4 | – | Sell |
-13,400
| Closed | -$193K | – | 1031 |
|
|
2018
Q3 | $193K | Buy |
+13,400
| New | +$193K | ﹤0.01% | 932 |
|
|
2013
Q4 | – | Sell |
-10,800
| Closed | -$132K | – | 990 |
|
|
2013
Q3 | $132K | Sell |
10,800
-531
| -5% | -$6.49K | ﹤0.01% | 882 |
|
|
2013
Q2 | $150K | Buy |
+11,331
| New | +$150K | ﹤0.01% | 919 |
|